GPO Plus Past Earnings Performance
Past criteria checks 0/6
GPO Plus's earnings have been declining at an average annual rate of -32.3%, while the Healthcare industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 59.9% per year.
Key information
-32.3%
Earnings growth rate
-22.8%
EPS growth rate
Healthcare Industry Growth | 8.5% |
Revenue growth rate | 59.9% |
Return on equity | n/a |
Net Margin | -119.0% |
Last Earnings Update | 31 Jan 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How GPO Plus makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Jan 24 | 4 | -4 | 4 | 0 |
31 Oct 23 | 3 | -4 | 4 | 0 |
31 Jul 23 | 2 | -5 | 5 | 0 |
30 Apr 23 | 1 | -4 | 4 | 0 |
31 Jan 23 | 0 | -3 | 3 | 0 |
31 Oct 22 | 1 | -9 | 9 | 0 |
31 Jul 22 | 1 | -11 | 10 | 0 |
30 Apr 22 | 1 | -30 | 29 | 0 |
31 Jan 22 | 1 | -29 | 29 | 0 |
31 Oct 21 | 1 | -23 | 23 | 0 |
31 Jul 21 | 1 | -20 | 20 | 0 |
30 Apr 21 | 1 | -1 | 1 | 0 |
31 Jan 21 | 1 | 0 | 1 | 0 |
31 Oct 20 | 0 | 0 | 0 | 0 |
31 Jul 20 | 0 | 0 | 0 | 0 |
30 Apr 20 | 0 | 0 | 0 | 0 |
31 Jan 20 | 0 | 0 | 0 | 0 |
31 Oct 19 | 0 | 0 | 0 | 0 |
31 Jul 19 | 0 | 0 | 0 | 0 |
30 Apr 19 | 0 | 0 | 0 | 0 |
31 Jan 19 | 0 | 0 | 0 | 0 |
31 Oct 18 | 0 | 0 | 0 | 0 |
31 Jul 18 | 0 | 0 | 0 | 0 |
30 Apr 18 | 0 | 0 | 0 | 0 |
31 Jan 18 | 0 | 0 | 0 | 0 |
31 Oct 17 | 0 | 0 | 0 | 0 |
31 Jul 17 | 0 | 0 | 0 | 0 |
30 Apr 17 | 0 | 0 | 0 | 0 |
Quality Earnings: GPOX is currently unprofitable.
Growing Profit Margin: GPOX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GPOX is unprofitable, and losses have increased over the past 5 years at a rate of 32.3% per year.
Accelerating Growth: Unable to compare GPOX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: GPOX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (15.1%).
Return on Equity
High ROE: GPOX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.